Coverage
-
June 19, 2013
The U.S. Food and Drug Administration's losing battle against wider access to Plan B emergency contraception was widely viewed as politically motivated, and undermined its credibility in a way that could embolden pharmaceutical companies to challenge the agency when it rejects approval for other controversial products, experts say.
6 other articles on this case.
View all »